Porcine neural cell product-HD

Drug Profile

Porcine neural cell product-HD

Alternative Names: NeuroCell-HD

Latest Information Update: 27 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Diacrin; Genzyme Corporation
  • Developer Diacrin
  • Class Neuroprotectants
  • Mechanism of Action Dopaminergic cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Huntington's disease

Most Recent Events

  • 17 Oct 2002 Discontinued - Phase-I for Huntington's disease in USA (Intracerebal)
  • 27 Jun 2001 This product is still in active development
  • 09 Jul 1998 Phase-I clinical trials for Huntington's disease in USA (Intracerebal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top